Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.

Source:http://linkedlifedata.com/resource/pubmed/id/16079165

Download in:

View as

General Info

PMID
16079165